Past Events

Results 661 to 672 of 1435
Nordic Reform Conference

Nordic Reform Conference

Oslo, Norway
22 November 2017 - 23 November 2017
The Association for Safer Drug Policies has invited some of the world’s leading voices in drug policy reform to share their harm prevention strategies.
European HIV-Hepatitis testing week 2017

European HIV-Hepatitis testing week 2017

Europe
16 November 2017 - 23 November 2017
Now in its fifth year and the third time hepatitis testing has been included, European HIV-Hepatitis Testing Week will take place from 17-24 November 2017.
CND Intersessional Meeting

CND Intersessional Meeting

Vienna, Austria
15 November 2017 - 16 November 2017
This thematic discussion will focus Chapter 6 of the Outcome Document (International Cooperation) and the way forward towards 2019.
HIT Hot Topics 2018

HIT Hot Topics 2018

Liverpool, United Kingdom
9 November 2017
HIT Hot Topics reunites hundreds of drug policy reform and harm reduction activists for a day of reflection and debate.
27th IFNGO World Conference

27th IFNGO World Conference

Macau
5 November 2017 - 7 November 2017
The 27th IFNGO world conference will be held in Macau. Abstracts open 1/3/17, close 30/4/17.
39th meeting of the Expert Committee on Drug Dependence (ECDD - WHO)

39th meeting of the Expert Committee on Drug Dependence (ECDD - WHO)

Geneva, Switzerland
5 November 2017 - 9 November 2017
The Thirty-ninth meeting of the Expert Committee on Drug Dependence (ECDD) will be held in Geneva, Switzerland, 6 – 10 November 2017. At the meeting, the ECDD will review a number of psychoactive substances with potential for dependence, abuse and harm to health and make recommendations to the UN Secretary-General, on the need for and level of international control of these substances. The following substances will be reviewed: 1. Ocfentanil 2. Furanyl fentanyl (Fu-F) 3. Acryloylfentanyl (Acrylfentanyl) 4. Carfentanil 5. 4-fluoroisobutyrfentanyl (4-FIBF, pFIBF) 6. Tetrahydrofuranylfentanyl (THF-F) 7. 4-fluoroamphetamine (4-FA) 8. AB-PINACA 9. AB-CHMINACA 10. 5F-PB-22 11. UR-144 12. 5F-ADB 13. Etizolam 14. Pregabalin 15. Tramadol 16. Cannabidiol (CBD). For more information, please do not hesitate to contact the Secretariat at: ecddsecretariat@who.int
The Museum of Drug Policy

The Museum of Drug Policy

47 Tanner Street, London, SE1 3LE, United Kingdom
2 November 2017 - 4 November 2017
A free pop-up exhibition and cultural hub featuring live programming and art from around the world, highlighting how drug policies impact and shape our communities.
World Hepatitis Summit 2017

World Hepatitis Summit 2017

São Paulo, Brazil
31 October 2017 - 2 November 2017
The 2017 theme is "Implementing the Global Health Sector Strategy on Viral Hepatitis (GHSS): Towards the elimination of hepatitis as a public health threat".
A briefing on human rights and drug policies

A briefing on human rights and drug policies

Geneva, Switzerland
31 October 2017
This Intersessional Briefing will provide information to delegates and serves as a platform for discussion on how the human rights system can contribute to the ongoing process, supplementing work by other agencies in the UN system and delivering on its mandate.
120th Session of  INCB

120th Session of INCB

Vienna, Austria
30 October 2017 - 16 November 2017
The International Narcotics Control Board will hold its 120th session on 31st October.